Hot Dermatology Space Gains New Player in Start-up Aclaris

By Jennifer BoggsManaging Editor

Friday, November 16, 2012

As a handful of global pharma firms vie for bigger portions of the increasingly popular dermatology market, a new entrant entered the space earlier this year: Aclaris Therapeutics Inc., which launched with a $21 million Series A round to advance its lead topical dermatology program into clinical testing.